Common Contracts
7 similar Underwriting Agreement contracts by Applied Genetic Technologies Corp, Cabaletta Bio, Inc., Evolus, Inc., others
EVOLUS, INC. (a Delaware corporation) 3,554,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • March 13th, 2024 • Evolus, Inc. • Pharmaceutical preparations • New York
Evolus, Inc., a Delaware corporation (the “Company”), confirms its agreement with Leerink Partners LLC (“Leerink Partners”), Stifel, Nicolaus & Company, Incorporated (“Stifel”) and each of the other Underwriters named in Schedule A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for which Leerink Partners and Stifel are acting as representatives (in such capacity, the “Representatives”), with respect to (i) the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of shares of common stock, par value $0.00001 per share, of the Company (“Common Stock”), set forth in Schedule A hereto, and (ii) the grant by the Company to the Underwriters, acting severally and not jointly, of the option described in Section 2(b) hereof to purchase all or any part of 533,100 additional shares of Common Stock. The aforesaid 3,554,000 shares of Co
CABALETTA BIO, INC. 7,250,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • May 18th, 2023 • Cabaletta Bio, Inc. • Biological products, (no disgnostic substances)
•] Shares1 Surgalign Holdings, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 25th, 2021 • Surgalign Holdings, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
IMMUNOMEDICS, INC. 14,736,860 Shares of Common Stock UNDERWRITING AGREEMENT Dated: April 28, 2020Underwriting Agreement • May 1st, 2020 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New York
APPLIED GENETIC TECHNOLOGIES CORPORATION [•] Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 5th, 2020 • Applied Genetic Technologies Corp • Biological products, (no disgnostic substances) • New York
X4 PHARMACEUTICALS, INC. 5,670,000 Shares of Common Stock Pre-Funded Warrants to Purchase 2,130,000 Shares of Common Stock Class A Warrants to Purchase 3,900,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • April 15th, 2019 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • New York
Page SECTION 1. Representations and Warranties 2 SECTION 2. Sale and Delivery to Underwriters; Closing 15 SECTION 3. Covenants of the Company 17 SECTION 4. Payment of Expenses 21 SECTION 5. Conditions of Underwriters’ Obligations 22 SECTION 6....Underwriting Agreement • May 10th, 2018 • Spire Inc • Natural gas distribution • New York
